Drug patents …
… from Kazakhstan to Kalamazoo
Proactively manage your pharmacy inventory
Anticipate generic drug launch
Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Find generic entry opportunities
Manage your formulary budget
|Title:||Meta chloro or fluoro substituted alpha-T-butylaminopropionphenones in the treatment of depression|
|Abstract:||The compounds m-chloro-.alpha.-t-butylaminopropiophenone and m-fluoro-.alpha.-t-butylaminopropiophenone or salts thereof. The compounds are useful in the treatment of mammals suffering from a depressed state.|
|Inventor(s):||Mehta; Nariman B. (Raleigh, NC)|
|Assignee:||Burroughs Wellcome Co. (Research Triangle Park, NC)|
Patent Claim Types:|
see list of patent claims
|Use; Composition; Compound; Dosage form; Formulation;|
|Foriegn Application Priority Data|
|Foreign Country||Foreign Patent Number||Foreign Patent Date|
|United Kingdom||59231/69||Dec 4, 1969|
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.